nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—ABCC2—Spironolactone—dilated cardiomyopathy	0.22	0.42	CbGbCtD
Cisplatin—ABCC2—Furosemide—dilated cardiomyopathy	0.151	0.287	CbGbCtD
Cisplatin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0816	0.156	CbGbCtD
Cisplatin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0718	0.137	CbGbCtD
Cisplatin—CYP2C9—cardial valve—dilated cardiomyopathy	0.0171	0.162	CbGeAlD
Cisplatin—Ototoxicity—Furosemide—dilated cardiomyopathy	0.0113	0.0547	CcSEcCtD
Cisplatin—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00843	0.0407	CcSEcCtD
Cisplatin—Diuresis—Furosemide—dilated cardiomyopathy	0.00732	0.0354	CcSEcCtD
Cisplatin—Tetany—Furosemide—dilated cardiomyopathy	0.00697	0.0337	CcSEcCtD
Cisplatin—SLC31A2—myocardium—dilated cardiomyopathy	0.00552	0.0521	CbGeAlD
Cisplatin—MT1A—heart—dilated cardiomyopathy	0.0047	0.0444	CbGeAlD
Cisplatin—SOD1—cardiac ventricle—dilated cardiomyopathy	0.00452	0.0427	CbGeAlD
Cisplatin—Ulcer—Spironolactone—dilated cardiomyopathy	0.00441	0.0213	CcSEcCtD
Cisplatin—SOD1—myocardium—dilated cardiomyopathy	0.00425	0.0402	CbGeAlD
Cisplatin—ATP7B—heart—dilated cardiomyopathy	0.00422	0.0398	CbGeAlD
Cisplatin—SLC31A1—myocardium—dilated cardiomyopathy	0.00415	0.0391	CbGeAlD
Cisplatin—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0041	0.0198	CcSEcCtD
Cisplatin—MT2A—heart—dilated cardiomyopathy	0.00392	0.037	CbGeAlD
Cisplatin—SLC31A2—heart—dilated cardiomyopathy	0.00385	0.0364	CbGeAlD
Cisplatin—ATP7B—cardiac atrium—dilated cardiomyopathy	0.00361	0.034	CbGeAlD
Cisplatin—ATP7A—heart—dilated cardiomyopathy	0.00339	0.032	CbGeAlD
Cisplatin—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00328	0.0159	CcSEcCtD
Cisplatin—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.00322	0.0304	CbGeAlD
Cisplatin—Blindness—Lisinopril—dilated cardiomyopathy	0.00308	0.0149	CcSEcCtD
Cisplatin—ABCC5—myocardium—dilated cardiomyopathy	0.00303	0.0286	CbGeAlD
Cisplatin—SOD1—heart—dilated cardiomyopathy	0.00297	0.028	CbGeAlD
Cisplatin—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00293	0.0142	CcSEcCtD
Cisplatin—SLC31A1—heart—dilated cardiomyopathy	0.00289	0.0273	CbGeAlD
Cisplatin—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00286	0.0138	CcSEcCtD
Cisplatin—GSTM1—heart—dilated cardiomyopathy	0.00282	0.0267	CbGeAlD
Cisplatin—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00277	0.0134	CcSEcCtD
Cisplatin—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00274	0.0132	CcSEcCtD
Cisplatin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00273	0.0132	CcSEcCtD
Cisplatin—GSTP1—cardiac ventricle—dilated cardiomyopathy	0.0027	0.0254	CbGeAlD
Cisplatin—MPO—myocardium—dilated cardiomyopathy	0.00261	0.0246	CbGeAlD
Cisplatin—SOD1—cardiac atrium—dilated cardiomyopathy	0.00254	0.024	CbGeAlD
Cisplatin—GSTP1—myocardium—dilated cardiomyopathy	0.00253	0.0239	CbGeAlD
Cisplatin—SLC31A1—cardiac atrium—dilated cardiomyopathy	0.00248	0.0234	CbGeAlD
Cisplatin—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00245	0.0118	CcSEcCtD
Cisplatin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00239	0.0115	CcSEcCtD
Cisplatin—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00231	0.0112	CcSEcCtD
Cisplatin—Renal failure—Spironolactone—dilated cardiomyopathy	0.0023	0.0111	CcSEcCtD
Cisplatin—ABCC5—heart—dilated cardiomyopathy	0.00212	0.02	CbGeAlD
Cisplatin—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.0021	0.0102	CcSEcCtD
Cisplatin—NQO1—heart—dilated cardiomyopathy	0.00198	0.0187	CbGeAlD
Cisplatin—Polyuria—Furosemide—dilated cardiomyopathy	0.00188	0.00907	CcSEcCtD
Cisplatin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00185	0.00895	CcSEcCtD
Cisplatin—Deafness—Furosemide—dilated cardiomyopathy	0.00184	0.0089	CcSEcCtD
Cisplatin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00183	0.00882	CcSEcCtD
Cisplatin—MPO—heart—dilated cardiomyopathy	0.00182	0.0172	CbGeAlD
Cisplatin—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00181	0.0171	CbGeAlD
Cisplatin—GSTP1—heart—dilated cardiomyopathy	0.00177	0.0167	CbGeAlD
Cisplatin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00175	0.00847	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0017	0.00823	CcSEcCtD
Cisplatin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00169	0.00818	CcSEcCtD
Cisplatin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00167	0.00809	CcSEcCtD
Cisplatin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00166	0.008	CcSEcCtD
Cisplatin—Wheezing—Lisinopril—dilated cardiomyopathy	0.00165	0.00799	CcSEcCtD
Cisplatin—Malaise—Spironolactone—dilated cardiomyopathy	0.00165	0.00795	CcSEcCtD
Cisplatin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00163	0.00789	CcSEcCtD
Cisplatin—BCHE—cardiac ventricle—dilated cardiomyopathy	0.00163	0.0154	CbGeAlD
Cisplatin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00162	0.00781	CcSEcCtD
Cisplatin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.0016	0.00773	CcSEcCtD
Cisplatin—Irritability—Furosemide—dilated cardiomyopathy	0.00157	0.0076	CcSEcCtD
Cisplatin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00154	0.00746	CcSEcCtD
Cisplatin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00153	0.00741	CcSEcCtD
Cisplatin—Dehydration—Furosemide—dilated cardiomyopathy	0.00153	0.00741	CcSEcCtD
Cisplatin—GSTP1—cardiac atrium—dilated cardiomyopathy	0.00151	0.0143	CbGeAlD
Cisplatin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00151	0.00727	CcSEcCtD
Cisplatin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0015	0.00725	CcSEcCtD
Cisplatin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00149	0.00719	CcSEcCtD
Cisplatin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00148	0.00717	CcSEcCtD
Cisplatin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00146	0.00704	CcSEcCtD
Cisplatin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0014	0.00675	CcSEcCtD
Cisplatin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00137	0.00662	CcSEcCtD
Cisplatin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00136	0.00656	CcSEcCtD
Cisplatin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00134	0.00647	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00129	0.00621	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00128	0.00617	CcSEcCtD
Cisplatin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00126	0.0061	CcSEcCtD
Cisplatin—Renal failure—Furosemide—dilated cardiomyopathy	0.00125	0.00603	CcSEcCtD
Cisplatin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00124	0.006	CcSEcCtD
Cisplatin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00123	0.00593	CcSEcCtD
Cisplatin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0012	0.0058	CcSEcCtD
Cisplatin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00119	0.00577	CcSEcCtD
Cisplatin—Irritability—Lisinopril—dilated cardiomyopathy	0.00118	0.0057	CcSEcCtD
Cisplatin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00118	0.00569	CcSEcCtD
Cisplatin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00116	0.0056	CcSEcCtD
Cisplatin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00115	0.00556	CcSEcCtD
Cisplatin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00113	0.00546	CcSEcCtD
Cisplatin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00113	0.00544	CcSEcCtD
Cisplatin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00112	0.0054	CcSEcCtD
Cisplatin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00112	0.0054	CcSEcCtD
Cisplatin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00111	0.00538	CcSEcCtD
Cisplatin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00111	0.00534	CcSEcCtD
Cisplatin—Visual impairment—Furosemide—dilated cardiomyopathy	0.0011	0.00531	CcSEcCtD
Cisplatin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0011	0.0053	CcSEcCtD
Cisplatin—BCHE—heart—dilated cardiomyopathy	0.00107	0.0101	CbGeAlD
Cisplatin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00107	0.00515	CcSEcCtD
Cisplatin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00106	0.00514	CcSEcCtD
Cisplatin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00105	0.00506	CcSEcCtD
Cisplatin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00104	0.00503	CcSEcCtD
Cisplatin—ABCG2—heart—dilated cardiomyopathy	0.00104	0.00977	CbGeAlD
Cisplatin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00103	0.00498	CcSEcCtD
Cisplatin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00102	0.00492	CcSEcCtD
Cisplatin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00102	0.00492	CcSEcCtD
Cisplatin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00102	0.0049	CcSEcCtD
Cisplatin—Malnutrition—Furosemide—dilated cardiomyopathy	0.000993	0.0048	CcSEcCtD
Cisplatin—Erythema—Furosemide—dilated cardiomyopathy	0.000993	0.0048	CcSEcCtD
Cisplatin—Flatulence—Furosemide—dilated cardiomyopathy	0.000978	0.00473	CcSEcCtD
Cisplatin—CYP2B6—heart—dilated cardiomyopathy	0.000955	0.00902	CbGeAlD
Cisplatin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000954	0.00461	CcSEcCtD
Cisplatin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000947	0.00457	CcSEcCtD
Cisplatin—CYP2C9—heart—dilated cardiomyopathy	0.000946	0.00893	CbGeAlD
Cisplatin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00094	0.00454	CcSEcCtD
Cisplatin—Rash—Spironolactone—dilated cardiomyopathy	0.000939	0.00454	CcSEcCtD
Cisplatin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000938	0.00453	CcSEcCtD
Cisplatin—Renal failure—Lisinopril—dilated cardiomyopathy	0.000937	0.00453	CcSEcCtD
Cisplatin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000936	0.00452	CcSEcCtD
Cisplatin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000934	0.00451	CcSEcCtD
Cisplatin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000934	0.00451	CcSEcCtD
Cisplatin—Anaemia—Furosemide—dilated cardiomyopathy	0.000918	0.00443	CcSEcCtD
Cisplatin—BCHE—cardiac atrium—dilated cardiomyopathy	0.000916	0.00865	CbGeAlD
Cisplatin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000901	0.00435	CcSEcCtD
Cisplatin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000889	0.00429	CcSEcCtD
Cisplatin—Nausea—Spironolactone—dilated cardiomyopathy	0.000885	0.00427	CcSEcCtD
Cisplatin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000871	0.00421	CcSEcCtD
Cisplatin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000845	0.00408	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000839	0.00405	CcSEcCtD
Cisplatin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000839	0.00405	CcSEcCtD
Cisplatin—PTGS2—heart—dilated cardiomyopathy	0.000825	0.00779	CbGeAlD
Cisplatin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00081	0.00391	CcSEcCtD
Cisplatin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000798	0.00385	CcSEcCtD
Cisplatin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000795	0.00384	CcSEcCtD
Cisplatin—Flushing—Lisinopril—dilated cardiomyopathy	0.000794	0.00384	CcSEcCtD
Cisplatin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000793	0.00383	CcSEcCtD
Cisplatin—Skin disorder—Furosemide—dilated cardiomyopathy	0.000787	0.0038	CcSEcCtD
Cisplatin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000783	0.00378	CcSEcCtD
Cisplatin—Anorexia—Furosemide—dilated cardiomyopathy	0.000772	0.00373	CcSEcCtD
Cisplatin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000771	0.00373	CcSEcCtD
Cisplatin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000764	0.00369	CcSEcCtD
Cisplatin—Hypotension—Furosemide—dilated cardiomyopathy	0.000757	0.00366	CcSEcCtD
Cisplatin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000756	0.00365	CcSEcCtD
Cisplatin—Erythema—Lisinopril—dilated cardiomyopathy	0.000745	0.0036	CcSEcCtD
Cisplatin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000745	0.0036	CcSEcCtD
Cisplatin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000734	0.00355	CcSEcCtD
Cisplatin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000727	0.00351	CcSEcCtD
Cisplatin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000716	0.00346	CcSEcCtD
Cisplatin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000704	0.0034	CcSEcCtD
Cisplatin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000702	0.00339	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000699	0.00338	CcSEcCtD
Cisplatin—Tremor—Lisinopril—dilated cardiomyopathy	0.000698	0.00337	CcSEcCtD
Cisplatin—Pain—Furosemide—dilated cardiomyopathy	0.000693	0.00335	CcSEcCtD
Cisplatin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000691	0.00334	CcSEcCtD
Cisplatin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000688	0.00333	CcSEcCtD
Cisplatin—Malaise—Lisinopril—dilated cardiomyopathy	0.000672	0.00324	CcSEcCtD
Cisplatin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000668	0.00323	CcSEcCtD
Cisplatin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000667	0.00322	CcSEcCtD
Cisplatin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00064	0.00309	CcSEcCtD
Cisplatin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000634	0.00306	CcSEcCtD
Cisplatin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000632	0.00305	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00063	0.00304	CcSEcCtD
Cisplatin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000627	0.00303	CcSEcCtD
Cisplatin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000608	0.00294	CcSEcCtD
Cisplatin—Oedema—Lisinopril—dilated cardiomyopathy	0.000608	0.00294	CcSEcCtD
Cisplatin—Infection—Lisinopril—dilated cardiomyopathy	0.000604	0.00292	CcSEcCtD
Cisplatin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000597	0.00288	CcSEcCtD
Cisplatin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000595	0.00288	CcSEcCtD
Cisplatin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000593	0.00287	CcSEcCtD
Cisplatin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00059	0.00285	CcSEcCtD
Cisplatin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000588	0.00284	CcSEcCtD
Cisplatin—Asthenia—Furosemide—dilated cardiomyopathy	0.000581	0.00281	CcSEcCtD
Cisplatin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000579	0.0028	CcSEcCtD
Cisplatin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000568	0.00274	CcSEcCtD
Cisplatin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000554	0.00268	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000554	0.00268	CcSEcCtD
Cisplatin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000546	0.00264	CcSEcCtD
Cisplatin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000542	0.00262	CcSEcCtD
Cisplatin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000528	0.00255	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000525	0.00254	CcSEcCtD
Cisplatin—Pain—Lisinopril—dilated cardiomyopathy	0.00052	0.00251	CcSEcCtD
Cisplatin—Vomiting—Furosemide—dilated cardiomyopathy	0.000515	0.00249	CcSEcCtD
Cisplatin—Rash—Furosemide—dilated cardiomyopathy	0.000511	0.00247	CcSEcCtD
Cisplatin—ABCB1—heart—dilated cardiomyopathy	0.000511	0.00482	CbGeAlD
Cisplatin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00051	0.00247	CcSEcCtD
Cisplatin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000501	0.00242	CcSEcCtD
Cisplatin—Nausea—Furosemide—dilated cardiomyopathy	0.000481	0.00232	CcSEcCtD
Cisplatin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000481	0.00232	CcSEcCtD
Cisplatin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000448	0.00216	CcSEcCtD
Cisplatin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000436	0.00211	CcSEcCtD
Cisplatin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000416	0.00201	CcSEcCtD
Cisplatin—GSTT1—Metabolism—TAZ—dilated cardiomyopathy	0.000403	0.00248	CbGpPWpGaD
Cisplatin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000386	0.00187	CcSEcCtD
Cisplatin—ATP7A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000386	0.00237	CbGpPWpGaD
Cisplatin—Rash—Lisinopril—dilated cardiomyopathy	0.000383	0.00185	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000383	0.00236	CbGpPWpGaD
Cisplatin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000383	0.00185	CcSEcCtD
Cisplatin—SOD1—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000382	0.00235	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000371	0.00228	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000371	0.00228	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—SDHA—dilated cardiomyopathy	0.000365	0.00224	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000364	0.00224	CbGpPWpGaD
Cisplatin—Nausea—Lisinopril—dilated cardiomyopathy	0.000361	0.00174	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00036	0.00222	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000355	0.00218	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000353	0.00217	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000353	0.00217	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VCL—dilated cardiomyopathy	0.000349	0.00215	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000333	0.00205	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000327	0.00201	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000326	0.002	CbGpPWpGaD
Cisplatin—CYP4A11—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000321	0.00197	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000317	0.00195	CbGpPWpGaD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—dilated cardiomyopathy	0.000315	0.00194	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000314	0.00193	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TNF—dilated cardiomyopathy	0.000311	0.00191	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000306	0.00188	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000299	0.00184	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000291	0.00179	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000291	0.00179	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00029	0.00178	CbGpPWpGaD
Cisplatin—CYP4A11—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000289	0.00178	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000288	0.00177	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000288	0.00177	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000284	0.00175	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.000284	0.00175	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000283	0.00174	CbGpPWpGaD
Cisplatin—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000277	0.0017	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000276	0.0017	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000273	0.00168	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.000272	0.00167	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.000271	0.00167	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000271	0.00167	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000271	0.00166	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000269	0.00165	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—TAZ—dilated cardiomyopathy	0.00026	0.0016	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000258	0.00159	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000253	0.00156	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000249	0.00153	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000247	0.00152	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000243	0.00149	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000239	0.00147	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000236	0.00145	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—SDHA—dilated cardiomyopathy	0.000235	0.00144	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000235	0.00144	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000234	0.00144	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000234	0.00144	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000231	0.00142	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000229	0.00141	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000226	0.00139	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000225	0.00139	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—TAZ—dilated cardiomyopathy	0.000221	0.00136	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000221	0.00136	CbGpPWpGaD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000216	0.00133	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000216	0.00133	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—TAZ—dilated cardiomyopathy	0.000215	0.00132	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000215	0.00132	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000215	0.00132	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ANKRD1—dilated cardiomyopathy	0.000205	0.00126	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000202	0.00124	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000202	0.00124	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000202	0.00124	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—SDHA—dilated cardiomyopathy	0.0002	0.00123	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0002	0.00123	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000197	0.00121	CbGpPWpGaD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000195	0.0012	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—SDHA—dilated cardiomyopathy	0.000195	0.0012	CbGpPWpGaD
Cisplatin—XDH—Metabolism—TAZ—dilated cardiomyopathy	0.000193	0.00119	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000188	0.00116	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	0.000185	0.00114	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000185	0.00114	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000183	0.00113	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000181	0.00111	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00018	0.00111	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000176	0.00108	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—ITGB1—dilated cardiomyopathy	0.000175	0.00108	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000175	0.00108	CbGpPWpGaD
Cisplatin—XDH—Metabolism—SDHA—dilated cardiomyopathy	0.000175	0.00107	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000171	0.00105	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ANKRD1—dilated cardiomyopathy	0.000171	0.00105	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00017	0.00105	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00017	0.00105	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.00017	0.00104	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000168	0.00103	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	0.000167	0.00103	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000161	0.000991	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—TAZ—dilated cardiomyopathy	0.00016	0.000987	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000158	0.000974	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000158	0.000971	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000152	0.000936	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000151	0.000927	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—CD36—dilated cardiomyopathy	0.000149	0.000919	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000148	0.000911	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000148	0.000911	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000147	0.000901	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000147	0.000901	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—SDHA—dilated cardiomyopathy	0.000145	0.000893	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000145	0.000893	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ITGB1—dilated cardiomyopathy	0.000143	0.000882	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000142	0.000874	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—RAC1—dilated cardiomyopathy	0.000141	0.000866	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000138	0.000847	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	0.000136	0.000839	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000136	0.000838	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000134	0.000825	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000132	0.000813	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000129	0.000791	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000129	0.000791	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000128	0.000787	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000127	0.000784	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000124	0.00076	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	0.000123	0.000759	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD36—dilated cardiomyopathy	0.000122	0.000752	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000118	0.000724	CbGpPWpGaD
Cisplatin—MT2A—Immune System—RAC1—dilated cardiomyopathy	0.000115	0.000709	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000113	0.000698	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.000111	0.000682	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.00011	0.000677	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000107	0.000656	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TAZ—dilated cardiomyopathy	0.000104	0.000641	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NPPA—dilated cardiomyopathy	0.000102	0.000629	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.0001	0.000615	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PSEN2—dilated cardiomyopathy	9.91e-05	0.000609	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	9.9e-05	0.000609	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GPX1—dilated cardiomyopathy	9.9e-05	0.000609	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CD36—dilated cardiomyopathy	9.64e-05	0.000593	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SDHA—dilated cardiomyopathy	9.43e-05	0.00058	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	9.41e-05	0.000579	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—RAF1—dilated cardiomyopathy	9.33e-05	0.000574	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	9.31e-05	0.000573	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.2e-05	0.000566	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.87e-05	0.000546	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.85e-05	0.000544	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.7e-05	0.000535	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AGT—dilated cardiomyopathy	8.68e-05	0.000534	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.62e-05	0.00053	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	8.51e-05	0.000523	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	8.42e-05	0.000518	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.23e-05	0.000506	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.08e-05	0.000497	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.01e-05	0.000492	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.01e-05	0.000492	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	7.96e-05	0.00049	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.76e-05	0.000477	CbGpPWpGaD
Cisplatin—MT2A—Immune System—RAF1—dilated cardiomyopathy	7.64e-05	0.00047	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	7.63e-05	0.000469	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.53e-05	0.000463	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.44e-05	0.000458	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	7.33e-05	0.000451	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.33e-05	0.000451	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.21e-05	0.000444	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	7.18e-05	0.000441	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	7e-05	0.000431	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	6.9e-05	0.000424	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	6.87e-05	0.000423	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.6e-05	0.000406	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.52e-05	0.000401	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	6.49e-05	0.000399	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GPX1—dilated cardiomyopathy	6.38e-05	0.000392	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.29e-05	0.000387	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	6.24e-05	0.000384	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CD36—dilated cardiomyopathy	6.21e-05	0.000382	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	6.19e-05	0.000381	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.17e-05	0.000379	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.91e-05	0.000363	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	5.81e-05	0.000358	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.77e-05	0.000355	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.75e-05	0.000354	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.6e-05	0.000344	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AGT—dilated cardiomyopathy	5.6e-05	0.000344	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	5.54e-05	0.000341	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	5.53e-05	0.00034	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GPX1—dilated cardiomyopathy	5.43e-05	0.000334	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	5.41e-05	0.000333	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	5.41e-05	0.000333	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GPX1—dilated cardiomyopathy	5.29e-05	0.000325	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CD36—dilated cardiomyopathy	5.28e-05	0.000325	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—dilated cardiomyopathy	5.24e-05	0.000322	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CD36—dilated cardiomyopathy	5.15e-05	0.000317	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.09e-05	0.000313	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	5.05e-05	0.000311	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.04e-05	0.00031	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RAC1—dilated cardiomyopathy	4.98e-05	0.000306	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AGT—dilated cardiomyopathy	4.76e-05	0.000293	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	4.75e-05	0.000292	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GPX1—dilated cardiomyopathy	4.74e-05	0.000292	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AGT—dilated cardiomyopathy	4.64e-05	0.000285	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CD36—dilated cardiomyopathy	4.62e-05	0.000284	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.6e-05	0.000283	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	4.55e-05	0.00028	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CD36—dilated cardiomyopathy	4.43e-05	0.000272	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	4.36e-05	0.000268	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.36e-05	0.000268	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	4.3e-05	0.000264	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AGT—dilated cardiomyopathy	4.16e-05	0.000256	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.09e-05	0.000251	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AGT—dilated cardiomyopathy	3.99e-05	0.000245	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NPPA—dilated cardiomyopathy	3.97e-05	0.000244	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.96e-05	0.000243	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.96e-05	0.000243	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GPX1—dilated cardiomyopathy	3.94e-05	0.000242	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.85e-05	0.000237	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PSEN2—dilated cardiomyopathy	3.84e-05	0.000236	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CD36—dilated cardiomyopathy	3.84e-05	0.000236	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.77e-05	0.000232	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.47e-05	0.000213	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AGT—dilated cardiomyopathy	3.46e-05	0.000213	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.45e-05	0.000212	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	3.35e-05	0.000206	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RAF1—dilated cardiomyopathy	3.3e-05	0.000203	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CD36—dilated cardiomyopathy	3.26e-05	0.000201	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3e-05	0.000185	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.97e-05	0.000183	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AGT—dilated cardiomyopathy	2.94e-05	0.000181	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.8e-05	0.000172	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.67e-05	0.000164	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.62e-05	0.000161	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPX1—dilated cardiomyopathy	2.56e-05	0.000158	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.55e-05	0.000157	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CD36—dilated cardiomyopathy	2.49e-05	0.000153	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.31e-05	0.000142	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.3e-05	0.000141	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	2.29e-05	0.000141	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—dilated cardiomyopathy	2.27e-05	0.000139	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.25e-05	0.000138	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AGT—dilated cardiomyopathy	2.25e-05	0.000138	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	2.23e-05	0.000137	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.03e-05	0.000125	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	2.01e-05	0.000123	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.93e-05	0.000119	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.76e-05	0.000108	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CD36—dilated cardiomyopathy	1.72e-05	0.000106	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.65e-05	0.000101	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.62e-05	9.99e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AGT—dilated cardiomyopathy	1.55e-05	9.51e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.49e-05	9.14e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAF1—dilated cardiomyopathy	1.28e-05	7.88e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.25e-05	7.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.22e-05	7.48e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.17e-05	7.18e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.14e-05	6.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.1e-05	6.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.02e-05	6.3e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—dilated cardiomyopathy	8.78e-06	5.4e-05	CbGpPWpGaD
